Effect of renal lipid accumulation on proximal tubule Na+/H + exchange and ammonium secretion

American Journal of Physiology - Renal Physiology

Volumn 294, Issue 6, 2008, Pages

  Bobulescu, I Alexandru ^a,b   Dubree, Michele ^a   Zhang, Jianning ^a   McLeroy, Paul ^a   Moe, Orson W ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Free fatty acids; Lipotoxicity; Metabolic syndrome; Na+ H+ exchanger 3; Zucker diabetic fatty rat

Indexed keywords

AMMONIA; FATTY ACID; GLUCOCORTICOID; INSULIN; SODIUM PROTON EXCHANGE PROTEIN 3; QUATERNARY AMMONIUM DERIVATIVE; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER 3; TRIACYLGLYCEROL;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET; KIDNEY PROXIMAL TUBULE; LIPID STORAGE; METABOLIC SYNDROME X; NEPHROLITHIASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT; SIGNAL TRANSDUCTION; STEATOSIS; URINE PH; ANIMAL; CELL CULTURE; CYTOLOGY; DIABETIC NEPHROPATHY; FAT INTAKE; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OPOSSUM; PH; PHYSIOLOGY; SECRETION; SPRAGUE DAWLEY RAT; ZUCKER RAT;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIETARY FATS; FATTY ACIDS; HYDROGEN-ION CONCENTRATION; INSULIN; KIDNEY TUBULES, PROXIMAL; MALE; METABOLIC SYNDROME X; OPOSSUMS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TRIGLYCERIDES;

EID: 48249103930     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00550.2007     Document Type: Article

References (69)

1. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65: 386-392, 2004.
2. Amemiya M, Loffing J, Lotscher M, Kaissling B, Alpern RJ, Moe OW. Expression of NHE-3 in the apical membrane of rat renal proximal tubule and thick ascending limb. Kidney Int 48: 1206-1215, 1995.
3. Amemiya M, Yamaji Y, Cano A, Moe OW, Alpern RJ. Acid incubation increases NHE-3 mRNA abundance in OKP cells. Am J Physiol Cell Physiol 269: C126-C133, 1995.
4. Bagby SP. Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? J Am Soc Nephrol 15: 2775-2791, 2004.
5. Bagnasco SM, Gaydos DS, Risquez A, Preuss HG. The regulation of renal ammoniagenesis in the rat by extracellular factors. III. Effects of various fuels on in vitro ammoniagenesis. Metabolism 32: 900-905, 1983.
6. + antiporter in OKP cells. Am J Physiol Renal Fluid Electrolyte Physiol 264: F1027-F1031, 1993.
7. Bickel CA, Knepper MA, Verbalis JG, Ecelbarger CA. Dysregulation of renal salt and water transport proteins in diabetic Zucker rats. Kidney Int 61: 2099-2110, 2002.
8. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int 69: 440-449, 2006.
9. + exchangers: physiology and link to hypertension and organ ischemia. Curr Opin Nephrol Hypertens 14: 485-494, 2005.
10. + exchanger-3 (NHE3) by activation of NHE3 exocytosis. Am J Physiol Renal Physiol 289: F685-F691, 2005.
11. + exchangers in renal regulation of acid-base balance. Semin Nephrol 26: 334-344, 2006.
12. Booth AG, Kenny AJ. A rapid method for the preparation of microvilli from rabbit kidney. Biochem J 142: 575-581, 1974.
13. Cameron MA, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17: 1422-1428, 2006.
14. Cameron MA, Sakhaee K. Uric acid nephrolithiasis. Urol Clin North Am 34: 335-346, 2007.
15. Chavez JA, Summers SA. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419: 101-109, 2003.
16. Chobanian MC, Hammerman MR. Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol Renal Fluid Electrolyte Physiol 253: F1171-F1177, 1987.
17. Clark JB, Palmer CJ, Shaw WN. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173: 68-75, 1983.
18. Cole JA, Forte LR, Krause WJ, Thorne PK. Clonal sublines that are morphologically and functionally distinct from parental OK cells. Am J Physiol Renal Fluid Electrolyte Physiol 256: F672-F679, 1989.
19. Danno H, Jincho Y, Budiyanto S, Furukawa Y, Kimura S. A simple enzymatic quantitative analysis of triglycerides in tissues. J Nutr Sci Vitaminol (Tokyo) 38: 517-521, 1992.
20. Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 20: 468-469, 2005.
21. Daudon M, Traxer O, Conort P, Lacour B, Jungers P. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17: 2026-2033, 2006.
22. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259, 1999.
23. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
24. + exchanger NHE3 by insulin. Am J Physiol Renal Physiol 292: F577-F585, 2007.
25. Gekle M. Renal tubule albumin transport. Annu Rev Physiol 67: 573-594, 2005.
26. Hulter HN, Sigala JF, Sebastian A. Effects of dexamethasone on renal and systemic acid-base metabolism. Kidney Int 20: 43-49, 1981.
27. Jiang T, Liebman SE, Lucia MS, Li J, Levi M. Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease. Kidney Int 68: 2608-2620, 2005.
28. Jiang T, Wang Z, Proctor G, Moskowitz S, Liebman SE, Rogers T, Lucia MS, Li J, Levi M. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280: 32317-32325, 2005.
29. + exchange activity in renal brush border membrane vesicles in response to metabolic acidosis: the role of glucocorticoids. Proc Natl Acad Sci USA 81: 630-634, 1984.
30. + exchanger. Am J Physiol Cell Physiol 241: C220-C226, 1981.
31. + exchanger 3: biphasic response and glucocorticoid dependence. Am J Physiol Renal Physiol 283: F532-F539, 2002.
32. Knepper MA, Packer R, Good DW. Ammonium transport in the kidney. Physiol Rev 69: 179-249, 1989.
33. Koyama K, Chen G, Lee Y, Unger RH. Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity. Am J Physiol Endocrinol Metab 273: E708-E713, 1997.
34. Krivosikova Z, Spustova V, Dzurik R. Participation of P-dependent and P-independent glutaminases in rat kidney ammoniagenesis and their modulation by metabolic acidosis, hippurate and insulin. Physiol Res 47: 177-183, 1998.
35. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci USA 91: 10878-10882, 1994.
36. Li S, Sato S, Yang X, Preisig PA, Alpern RJ. Pyk2 activation is integral to acid stimulation of sodium/hydrogen exchanger 3. J Clin Invest 114: 1782-1789, 2004.
37. Maalouf NM, Cameron MA, Moe OW, Adams-Huet B, Sakhaee K. Low urine pH: a novel feature of the metabolic syndrome (Abstract). Clin J Am Soc Nephrol 16: 2007.
38. Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13: 181-189, 2004.
39. Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adams-Huet B, Pak CY. Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65: 1422-1425, 2004.
40. Meyer C, Nadkarni V, Stumvoll M, Gerich J. Human kidney free fatty acid and glucose uptake: evidence for a renal glucose-fatty acid cycle. Am J Physiol Endocrinol Metab 273: E650-E654, 1997.
41. Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH, Unger RH. Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem 270: 1295-1299, 1995.
42. Moe OW. Acute regulation of proximal tubule apical membrane Na/H exchanger NHE-3: role of phosphorylation, protein trafficking, and regulatory factors. J Am Soc Nephrol 10: 2412-2425, 1999.
43. Moe OW, Miller RT, Horie S, Cano A, Preisig PA, Alpern RJ. Differential regulation of Na/H antiporter by acid in renal epithelial cells and fibroblasts. J Clin Invest 88: 1703-1708, 1991.
44. + antiporter activity in renal cortical apical membrane vesicles. Am J Physiol Renal Fluid Electrolyte Physiol 260: F130-F137, 1991.
45. Nagami GT. Ammonia production and secretion by the proximal tubule. Am J Kidney Dis 14: 258-261, 1989.
46. Nagami GT. Luminal secretion of ammonia in the mouse proximal tubule perfused in vitro. J Clin Invest 81: 159-164, 1988.
47. Nagami GT. Renal ammonia production and excretion. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW, and Giebisch G. Philadelphia, PA: Lippincott Williams & Wilkins, 2000, p. 1995-2014.
48. Pak CY, Sakhaee K, Moe O, Preminger GM, Poindexter JR, Peterson RD, Pietrow P, Ekeruo W. Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61: 523-527, 2003.
49. Pak CY, Sakhaee K, Peterson RD, Poindexter JR, Frawley WH. Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int 60: 757-761, 2001.
50. Reaven GM, Hollenbeck C, Jeng CY, Wu MS, Chen YD. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024, 1988.
51. Riazi S, Khan O, Tiwari S, Hu X, Ecelbarger CA. Rosiglitazone regulates ENaC and Na-K-2Cl cotransporter (NKCC2) abundance in the obese Zucker rat. Am J Nephrol 26: 245-257, 2006.
52. Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, Molitoris BA, Comper WD. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int 71: 504-513, 2007.
53. Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62: 971-979, 2002.
54. Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14: 281-287, 2003.
55. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94: 4637-4641, 1997.
56. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176, 2000.
57. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45: 42-72, 2006.
58. Sun L, Halaihel N, Zhang W, Rogers T, Levi M. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277: 18919-18927, 2002.
59. Thomas ME, Morrison AR, Schreiner GF. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1177-F1184, 1995.
60. Unger RH. Lipotoxic diseases. Annu Rev Med 53: 319-336, 2002.
61. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 44: 863-870, 1995.
62. Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J 15: 312-321, 2001.
63. Vinay P, Lemieux G, Cartier P, Ahmad M. Effect of fatty acids on renal ammoniagenesis in in vivo and in vitro studies. Am J Physiol 231: 880-887, 1976.
64. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2: 550-562, 2007.
65. + antiporter of brush border vesicles: studies with acridine orange uptake. Am J Physiol Renal Fluid Electrolyte Physiol 242: F733-F739, 1982.
66. Weinberg JM. Lipotoxicity. Kidney Int 70: 1560-1566, 2006.
67. Welbourne TC, Phenix P, Thornley-Brown C, Welbourne CJ. Triamcinolone activation of renal ammonia production. Proc Soc Exp Biol Med 153: 539-542, 1976.
68. Xu BE, Stippec S, Lenertz L, Lee BH, Zhang W, Lee YK, Cobb MH. WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J Biol Chem 279: 7826-7831, 2004.
69. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.